Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Traws Pharma, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 37 | 34 | −3 |
| Shares | 2.73M | 2.41M | −324.4K (−11.9%) |
| Value | $10.5M | $6.14M | −$4.32M (−41.3%) |
New holders (9)
Institutions that held Traws Pharma, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Advisers, LP | 295,312 | $753.0K | 0.00% |
| Anson Funds Management LP | 145,290 | $370.0K | 0.05% |
| Renaissance Technologies LLC | 133,627 | $341.0K | 0.00% |
| Two Sigma Investments, LP | 67,861 | $173.0K | 0.00% |
| Jump Financial, LLC | 23,182 | $59.0K | 0.00% |
| Millennium Management LLC | 13,551 | $35.0K | 0.00% |
| Virtu Financial LLC | 12,030 | $31.0K | 0.00% |
| Simplex Trading, LLC | 10,665 | $27.0K | 0.00% |
| Signaturefd, LLC | 400 | $1.00K | 0.00% |
Sold out (12)
Institutions that held Traws Pharma, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Alyeska Investment Group, L.P. | 250,000 | $958.0K |
| Pura Vida Investments, LLC | 150,000 | $575.0K |
| CVI Holdings, LLC | 128,604 | $493.0K |
| Walleye Capital LLC | 97,776 | $374.0K |
| Susquehanna International Group, LLP | 30,354 | $116.0K |
| Walleye Trading LLC | 27,259 | $104.0K |
| Goldman Sachs Group Inc | 14,898 | $57.0K |
| Engineers Gate Manager LP | 10,600 | $41.0K |
| FMR LLC | 404 | $2.00K |
| Cutler Group LP | 1 | $0 |
| Ironwood Financial, llc | 15 | $0 |
| Gerber Kawasaki Wealth & Investment Management | 1 | – |